Tschann Peter, Weigl Markus P, Lechner Daniel, Mittelberger Christa, Jäger Tarkan, Gruber Ricarda, Girotti Paolo N C, Mittermair Christof, Clemens Patrick, Attenberger Christian, Szeverinski Philipp, Brock Thomas, Frick Jürgen, Emmanuel Klaus, Königsrainer Ingmar, Presl Jaroslav
Department of General and Thoracic Surgery, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800 Feldkirch, Austria.
Department of Surgery, Paracelsus Medical University/Salzburger Landeskliniken (SALK), 5020 Salzburg, Austria.
Cancers (Basel). 2022 Jun 30;14(13):3208. doi: 10.3390/cancers14133208.
Robotic surgery represents a novel approach for the treatment of colorectal cancers and has been established as an important and effective method over the last years. The aim of this work was to evaluate the effect of a robotic program on oncological findings compared to conventional laparoscopic surgery within the first three years after the introduction.
All colorectal cancer patients from two centers that either received robotic-assisted or conventional laparoscopic surgery were included in a comparative study. A propensity-score-matched analysis was used to reduce confounding differences.
A laparoscopic resection (LR Group) was performed in 82 cases, and 93 patients were treated robotic-assisted surgery (RR Group). Patients' characteristics did not differ between groups. In right-sided resections, an intracorporeal anastomosis was significantly more often performed in the RR Group (LR Group: 5 (26.31%) vs. RR Group: 10 (76.92%), = 0.008). Operative time was shown to be significantly shorter in the LR Group (LR Group: 200 min (150-243) vs. 204 min (174-278), = 0.045). Conversions to open surgery did occur more often in the LR Group (LR Group: 16 (19.51%) vs. RR Group: 5 (5.38%), = 0.004). Postoperative morbidity, the number of harvested lymph nodes, quality of resection and postoperative tumor stage did not differ between groups.
In this study, we could clearly demonstrate robotic-assisted colorectal cancer surgery as effective, feasible and safe regarding postoperative morbidity and oncological findings compared to conventional laparoscopy during the introduction of a robotic system.
机器人手术是治疗结直肠癌的一种新方法,在过去几年中已成为一种重要且有效的治疗手段。本研究旨在评估在引入机器人手术项目后的头三年内,与传统腹腔镜手术相比,机器人手术对肿瘤学结果的影响。
来自两个中心的所有接受机器人辅助手术或传统腹腔镜手术的结直肠癌患者纳入一项对比研究。采用倾向评分匹配分析以减少混杂差异。
82例患者接受了腹腔镜切除术(LR组),93例患者接受了机器人辅助手术(RR组)。两组患者特征无差异。在右侧切除术方面,RR组更常进行体内吻合术(LR组:5例(26.31%) vs. RR组:10例(76.92%),P = 0.008)。LR组手术时间显著更短(LR组:200分钟(150 - 243) vs. 204分钟(174 - 278),P = 0.045)。LR组中转开腹手术的发生率更高(LR组:16例(19.51%) vs. RR组:5例(5.38%),P = 0.004)。两组术后发病率、获取的淋巴结数量、切除质量及术后肿瘤分期无差异。
在本研究中我们可以清楚地证明,在引入机器人手术系统期间与传统腹腔镜手术相比,机器人辅助结直肠癌手术在术后发病率和肿瘤学结果方面是有效、可行且安全的。